Health

brand new York City sues drug companies over opioid epidemic

brand new York City on Tuesday sued eight companies which make or distribute prescription opioids, blaming them for a deadly epidemic afflicting the most populous U.S. city. Mayor Bill de Blasio said the lawsuit seeks $500 million of damages to help fight the epidemic inside the city, which kills more people annually than homicides along with car accidents combined, including ...

Read More »

Flu shots aren’t perfect, scientists want to build universal vaccine

Scientists dream of creating a universal flu vaccine that will could be administered once in addition to also prevent sickness for a lifetime. Achieving that will can be likely still far off, yet various other improvements could be closer. One strategy companies have tried can be developing vaccines in various other places outside traditional chicken eggs. Seqirus, the vaccine unit ...

Read More »

Out-of-pocket health spending dropped after Obamacare rolled out

along with many people “continue to experience high-burden out-of-pocket along with premium spending,” the report said. Spending is usually considered “high-burden” if a family spends more than 10 percent of its income on out-of-pocket health costs, which can include deductibles, co-payments along with coinsurance. Premiums are considered high-burden if they exceed 9.5 percent of income. While high-burden out-of-pocket spending dropped ...

Read More »

West Virginia saw drop in opioid painkillers prescribed, deaths rose

Michael Goff, acting executive director of the pharmacy board, attributed the big decreases in opioids dispensed to the fact which “the word’s out” about the drugs. “There’s a lot of articles dealing with, doctors along with pharmacies are concerned, there’s lawsuits everywhere,” Goff said. West Virginia’s struggles with the opioid epidemic have received considerable attention via the media. along with ...

Read More »

Cramer’s guide to investing within the stock market’s winning sectors

Cramer started out with the newly revitalized bank stocks, many of which investors avoided for months in favor of financial technology stocks or payment processors. “Why? Primarily because long-term in addition to short-term interest rates were so low which … [the banks] couldn’t get the margins they needed on their loans or on your deposits,” Cramer said. As a result, ...

Read More »

ADT’s IPO was the latest insult to This kind of market

Bull markets as strong as This kind of one tend to spark an influx of initial public offerings, or IPOs, however CNBC’s Jim Cramer has seen something different playing out This kind of time around. “This kind of time we’ve hardly had any IPOs,” the “Mad Money” host said. “The reason? Because when we do get deals, they annihilate the ...

Read More »

Trends mirror Obamacare repeal efforts

The IUD business is actually booming from the age of Trump. At least 134,285 women have seen a doctor for an IUD prescription or insertion since Donald Trump was elected president, a 16 percent increase by the year before, according to data by Athenahealth. The number spiked immediately following Trump’s election in addition to fluctuated from the year after as ...

Read More »

Sanofi nears $11.4 billion deal for Bioverativ: source

Vincent Isore | IP3 | Getty Images View of the company logo at the general shareholders meeting of Sanofi on May 4, 2016. French drugmaker Sanofi will be close to acquiring biotechnology company Bioverativ for $105 a share, valuing the maker of hemophilia drugs at about $11.4 billion, according to a person familiar with the matter. The deal could be ...

Read More »